Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?
作者信息
Dix B R, Edwards S J, Braithwaite A W
机构信息
Cell Transformation Group, Department of Pathology, School of Medicine, University of Otago, Dunedin, New Zealand.
出版信息
J Virol. 2001 Jun;75(12):5443-7. doi: 10.1128/JVI.75.12.5443-5447.2001.
Abstract
摘要
相似文献
1
Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?
J Virol. 2001 Jun;75(12):5443-7. doi: 10.1128/JVI.75.12.5443-5447.2001.
2
Interactions between adenovirus proteins and the p53 pathway: the development of ONYX-015.
Semin Cancer Biol. 2000 Dec;10(6):453-9. doi: 10.1006/scbi.2000.0336.
3
Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity.
Cancer Cell. 2004 Dec;6(6):611-23. doi: 10.1016/j.ccr.2004.11.012.
4
The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells.
Oncogene. 1998 Jan 22;16(3):349-57. doi: 10.1038/sj.onc.1201540.
5
Analyses of single-amino-acid substitution mutants of adenovirus type 5 E1B-55K protein.
J Virol. 2001 May;75(9):4297-307. doi: 10.1128/JVI.75.9.4297-4307.2001.
6
Modification of the p53 transgene of a replication-competent adenovirus prevents mdm2- and E1b-55kD-mediated degradation of p53.
Cancer Gene Ther. 2006 Jul;13(7):686-95. doi: 10.1038/sj.cgt.7700936. Epub 2006 Feb 10.
7
Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts.
Cancer Res. 2002 Feb 1;62(3):764-72.
8
p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication.
J Virol. 1999 Jul;73(7):5333-44. doi: 10.1128/JVI.73.7.5333-5344.1999.
9
Replication of an E1B 55-kilodalton protein-deficient adenovirus (ONYX-015) is restored by gain-of-function rather than loss-of-function p53 mutants.
J Virol. 2003 Nov;77(21):11588-95. doi: 10.1128/jvi.77.21.11588-11595.2003.
10
Smarter viruses. Onyx pharmaceuticals, Inc.
Chem Biol. 2000 Dec;7(12):R223-4. doi: 10.1016/s1074-5521(00)00048-x.
引用本文的文献
1
A Renaissance for Oncolytic Adenoviruses?
Viruses. 2023 Jan 26;15(2):358. doi: 10.3390/v15020358.
2
Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments.
Front Oncol. 2022 Jan 6;11:799993. doi: 10.3389/fonc.2021.799993. eCollection 2021.
3
The role of NK cells in oncolytic viral therapy: a focus on hepatocellular carcinoma.
J Transl Genet Genom. 2021;5:304-322. doi: 10.20517/jtgg.2021.27. Epub 2021 Aug 4.
4
Oncolytic Replication of E1b-Deleted Adenoviruses.
Viruses. 2015 Nov 6;7(11):5767-79. doi: 10.3390/v7112905.
5
Oncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent mice.
BMC Cancer. 2015 Oct 16;15:716. doi: 10.1186/s12885-015-1731-x.
6
Adenoviral vectors for prodrug activation-based gene therapy for cancer.
Anticancer Agents Med Chem. 2014 Jan;14(1):115-26. doi: 10.2174/18715206113139990309.
7
Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia.
Oncotarget. 2013 Jun;4(6):860-74. doi: 10.18632/oncotarget.1018.
8
Molecular basis for viral selective replication in cancer cells: activation of CDK2 by adenovirus-induced cyclin E.
PLoS One. 2013;8(2):e57340. doi: 10.1371/journal.pone.0057340. Epub 2013 Feb 20.
9
Complete eradication of xenograft hepatoma by oncolytic adenovirus ZD55 harboring TRAIL-IETD-Smac gene with broad antitumor effect.
Hum Gene Ther. 2012 Sep;23(9):992-1002. doi: 10.1089/hum.2011.159. Epub 2012 Jul 20.
10
Sodium iodide symporter SPECT imaging of a patient treated with oncolytic adenovirus Ad5/3-Δ24-hNIS.
Mol Ther. 2011 Apr;19(4):629-31. doi: 10.1038/mt.2011.31.
本文引用的文献
1
2
3
Efficiency of adenovirus-mediated gene transfer to oropharyngeal epithelial cells correlates with cellular differentiation and human coxsackie and adenovirus receptor expression.
Hum Gene Ther. 2000 Nov 20;11(17):2365-75. doi: 10.1089/104303400750038471.
4
A functional complex of adenovirus proteins E1B-55kDa and E4orf6 is necessary to modulate the expression level of p53 but not its transcriptional activity.
J Virol. 2000 Dec;74(23):11407-12. doi: 10.1128/jvi.74.23.11407-11412.2000.
5
Oncolytic potential of E1B 55 kDa-deleted YKL-1 recombinant adenovirus: correlation with p53 functional status.
Int J Cancer. 2000 Nov 1;88(3):454-63. doi: 10.1002/1097-0215(20001101)88:3<454::aid-ijc19>3.0.co;2-t.
6
Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015).
Nat Med. 2000 Oct;6(10):1128-33. doi: 10.1038/80466.
7
8
a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer.
Nat Med. 2000 Aug;6(8):879-85. doi: 10.1038/78638.
9
Significant increase of adenovirus infectivity in glioma cell lines by extracellular domain of hCAR.
Oncol Res. 1999;11(11-12):513-21.
10
Efficient induction of cell death by adenoviruses requires binding of E1B55k and p53.
Cancer Res. 2000 May 15;60(10):2666-72.
Zotero 插件